Medicine recalls
|
| |
| Canada: Recall: SALOFALK 500mg: tablets may show black spots due to the oxidation of the active ingredient |
| |
Health Canada announces that AbbVie Corporation is recalling 2 lots of SALOFALK 500mg Tablet (Delayed-Release) (lot number: 247646A, 247647A) from retailers because some tablets in the affected lots may show black spots due to the oxidation of the active ingredient.
The product is indicated for the treatment of acute ulcerative colitis and prevention of relapse of Crohn’s disease in patients following bowel resection.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/salofalk-500mg-tablets-may-show-black-spots-due-oxidation-active-ingredient
In Hong Kong, Salofalk 500 Tab 500mg (HK-58825) is a pharmaceutical product registered by A. Menarini Hong Kong Limited (A. Menarini). The product is a prescription-only medicine. As confirmed by A. Menarini, the affected lots have not been imported into Hong Kong.
Ends/Friday, Apr 25, 2025
Issued at HKT 17:15
|
| |
